Chapter 10 - Oxygen‐Sensing Histidine‐Protein Kinases: Assays of Ligand Binding and Turnover of Response‐Regulator Substrates

Add time:09/08/2019    Source:sciencedirect.com

Heme‐based sensors are a recently discovered functional class of heme proteins that serve to detect physiological fluctuations in oxygen (O2), carbon monoxide (CO), or nitric oxide (NO). Many of these modular sensors detect heme ligands by coupling a histidine‐protein kinase to a heme‐binding domain. They typically bind O2, CO, and NO but respond only to one of these ligands. Usually, they are active in the ferrous unliganded state but are switched off by saturation with O2. The heme‐binding domains of these kinases are quite varied. They may feature a PAS fold, as in the Bradyrhizobium japonicum and Sinorhizobium melitoti FixL proteins, or a GAF fold, as in the Mycobacterium tuberculosis DevS and DosT proteins. Alternative folds, such as HNOB (also H‐NOX), have also been noted for such signal‐transducing kinases, although these classes are less well studied. Histidine‐protein kinases function in partnership with cognate response‐regulator substrate(s): usually transcription factors that they activate by phosphorylation. For example, FixL proteins specifically phosphorylate their FixJ partners, and DevS and DosT proteins phosphorylate DevR in response to hypoxia. We present methods for purifying these sensors and their protein substrates, verifying the quality of the preparations, determining the Kd values for binding of ligand and preparing sensors of known saturation, and measuring the rates of turnover (kcat) of the protein substrate by sensors of known heme status.

We also recommend Trading Suppliers and Manufacturers of FixJ protein (cas 136253-38-8). Pls Click Website Link as below: cas 136253-38-8 suppliers

Prev:Crystal structure of the response regulator spr1814 from Streptococcus pneumoniae reveals unique interdomain contacts among NarL family proteins
Next:Research paperNovel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity)